nach oben

Current Cardiovascular Imaging Reports

Erschienen in:

01.03.2023

Case-Based Discussion: Echocardiographic Assessment of Pulmonary Hypertension

verfasst von: Brigitte Kazzi, Allison G. Hays, Lena M. Mathews, Erin D. Michos, Stephen C. Mathai, Monica Mukherjee

Erschienen in: Current Cardiovascular Imaging Reports | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The purpose of the present work is to demonstrate how the application of echocardiography can be used for quantitative and qualitative assessment of the right heart size and function.

Recent Findings

Right ventricular failure is a major determinant of outcomes in pulmonary arterial hypertension and can be evaluated with 2D and Doppler echocardiography.

Summary

Echocardiography allows for the assessment of the right ventricular morphology, function, and hemodynamics. In this case-based review, we present a case of scleroderma-pulmonary arterial hypertension patient and discuss the implications of an echocardiographic evaluation in the diagnosis and prognostication of right ventricular failure.

Fisher MR, Forfia PR, Chamera E, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med. 2009;179(7):615–21. https://doi.org/10.1164/rccm.200811-1691OC.CrossRefPubMedPubMedCentral

Hung G, Mercurio V, Hsu S, Mathai SC, Shah AA, Mukherjee M. Progress in understanding, diagnosing, and managing cardiac complications of systemic sclerosis. Curr Rheumatol Rep. 2019;21(12):68. https://doi.org/10.1007/s11926-019-0867-0.CrossRefPubMed

Ruiz-Cano MJ, Escribano P, Alonso R, et al. Comparison of baseline characteristics and survival between patients with idiopathic and connective tissue disease–related pulmonary arterial hypertension. J Heart Lung Transplant. 2009;28(6):621–7. https://doi.org/10.1016/j.healun.2009.02.016.CrossRefPubMed

Vonk-Noordegraaf A, Haddad F, Chin KM, et al. Right heart adaptation to pulmonary arterial hypertension. J Am Coll Cardiol. 2013;62(25):D22–33. https://doi.org/10.1016/j.jacc.2013.10.027.CrossRefPubMed

Beshay S, Sahay S, Humbert M. Evaluation and management of pulmonary arterial hypertension. Respir Med. 2020;171:106099. https://doi.org/10.1016/j.rmed.2020.106099.CrossRefPubMed

Rubio-Rivas M, Homs NA, Cuartero D, Corbella X. The prevalence and incidence rate of pulmonary arterial hypertension in systemic sclerosis: systematic review and meta-analysis. Autoimmun Rev. 2021;20(1):102713. https://doi.org/10.1016/j.autrev.2020.102713.CrossRefPubMed

• Farrell C, Balasubramanian A, Hays AG, et al. A clinical approach to multimodality imaging in pulmonary hypertension. Front Cardiovasc Med. 2022;8:794706. https://doi.org/10.3389/fcvm.2021.794706. This paper discusses the role of non-invasive multimodality imaging, including echocardiography, computed tomography, nuclear imaging, and magnetic resonance imaging in the screening, classification, prognostication, and monitoring of pulmonary hypertension.CrossRefPubMedPubMedCentral

Coghlan JG, Denton CP, Grünig E, et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis. 2014;73(7):1340–9. https://doi.org/10.1136/annrheumdis-2013-203301.CrossRefPubMed

Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67–119. https://doi.org/10.1093/eurheartj/ehv317.CrossRefPubMed

10.

Gaynor SL, Maniar HS, Bloch JB, Steendijk P, Moon MR. Right atrial and ventricular adaptation to chronic right ventricular pressure overload. Circulation. 2005;112(9_supplement). https://doi.org/10.1161/CIRCULATIONAHA.104.517789

11.

• Lang RM, Cameli M, Sade LE, et al. Imaging assessment of the right atrium: anatomy and function. Eur Heart J - Cardiovasc Imaging. Published online January 25, 2022:jeac011. https://doi.org/10.1093/ehjci/jeac011. This paper discusses the structural changes of the right heart in pulmonary hypertension. It reviews assessment of right atrial anatomy, function, and hemodynamics.

12.

Raymond RJ, Hinderliter AL, Willis PW, et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol. 2002;39(7):1214–9. https://doi.org/10.1016/S0735-1097(02)01744-8.CrossRefPubMed

13.

Grapsa J, Gibbs JSR, Cabrita IZ, et al. The association of clinical outcome with right atrial and ventricular remodelling in patients with pulmonary arterial hypertension: study with real-time three-dimensional echocardiography. Eur Heart J - Cardiovasc Imaging. 2012;13(8):666–72. https://doi.org/10.1093/ehjci/jes003.CrossRefPubMed

14.

Bustamante-Labarta M, Perrone S, de la Fuente RL, et al. Right atrial size and tricuspid regurgitation severity predict mortality or transplantation in primary pulmonary hypertension. J Am Soc Echocardiogr. 2002;15(10):1160–4. https://doi.org/10.1067/mje.2002.123962.CrossRefPubMed

15.

Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685–713. https://doi.org/10.1016/j.echo.2010.05.010.CrossRefPubMed

16.

Jenei C, Kádár R, Balogh L, et al. Role of 3D echocardiography-determined atrial volumes in distinguishing between pre-capillary and post-capillary pulmonary hypertension. ESC Heart Fail. 2021;8(5):3975–83. https://doi.org/10.1002/ehf2.13496.CrossRefPubMedPubMedCentral

17.

Saito N, Kato S, Saito N, et al. Distinction between precapillary and postcapillary pulmonary hypertension by the atrial volume ratio on transthoracic echocardiography: atrial volume ratio for distinction of pulmonary hypertension. J Ultrasound Med. 2018;37(4):891–6. https://doi.org/10.1002/jum.14424.CrossRefPubMed

18.

Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39.e14. https://doi.org/10.1016/j.echo.2014.10.003.CrossRefPubMed

19.

• Addetia K, Miyoshi T, Citro R, et al. Two-dimensional echocardiographic right ventricular size and systolic function measurements stratified by sex, age, and ethnicity: results of the World Alliance of Societies of Echocardiography study. J Am Soc Echocardiogr. 2021;34(11):1148-1157.e1. https://doi.org/10.1016/j.echo.2021.06.013. This study is a multinational study of healthy adult individuals that showed that echocardiography cut-offs need to be adjusted for age, sex, and racial/ethnic differences.CrossRefPubMed

20.

Moceri P, Baudouy D, Chiche O, et al. Imaging in pulmonary hypertension: focus on the role of echocardiography. Arch Cardiovasc Dis. 2014;107(4):261–71. https://doi.org/10.1016/j.acvd.2014.02.005.CrossRefPubMed

21.

Ghio S, Pazzano AS, Klersy C, et al. Clinical and prognostic relevance of echocardiographic evaluation of right ventricular geometry in patients with idiopathic pulmonary arterial hypertension. Am J Cardiol. 2011;107(4):628–32. https://doi.org/10.1016/j.amjcard.2010.10.027.CrossRefPubMed

22.

van Wolferen SA, Marcus JT, Boonstra A, et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J. 2007;28(10):1250–7. https://doi.org/10.1093/eurheartj/ehl477.CrossRefPubMed

23.

Matsumura A, Shigeta A, Kasai H, et al. Interventricular septal curvature as an additional echocardiographic parameter for evaluating chronic thromboembolic pulmonary hypertension: a single-center retrospective study. BMC Pulm Med. 2021;21(1):328. https://doi.org/10.1186/s12890-021-01683-4.CrossRefPubMedPubMedCentral

24.

Brown SB, Raina A, Katz D, Szerlip M, Wiegers SE, Forfia PR. Longitudinal shortening accounts for the majority of right ventricular contraction and improves after pulmonary vasodilator therapy in normal subjects and patients with pulmonary arterial hypertension. Chest. 2011;140(1):27–33. https://doi.org/10.1378/chest.10-1136.CrossRefPubMed

25.

Motoji Y, Tanaka H, Fukuda Y, et al. Association of apical longitudinal rotation with right ventricular performance in patients with pulmonary hypertension: insights into overestimation of tricuspid annular plane systolic excursion. Echocardiography. 2016;33(2):207–15. https://doi.org/10.1111/echo.13036.CrossRefPubMed

26.

Unlu S, Farsalinos K, Ameloot K, et al. Apical traction: a novel visual echocardiographic parameter to predict survival in patients with pulmonary hypertension. Eur Heart J - Cardiovasc Imaging. 2016;17(2):177–83. https://doi.org/10.1093/ehjci/jev131.CrossRefPubMed

27.

Mathai SC, Sibley CT, Forfia PR, et al. Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertension. J Rheumatol. 2011;38(11):2410–8. https://doi.org/10.3899/jrheum.110512.CrossRefPubMed

28.

Hoette S, Creuzé N, Günther S, et al. RV Fractional area change and TAPSE as predictors of severe right ventricular dysfunction in pulmonary hypertension: a CMR study. Lung. 2018;196(2):157–64. https://doi.org/10.1007/s00408-018-0089-7.CrossRefPubMed

29.

Mertens LL, Friedberg MK. Imaging the right ventricle—current state of the art. Nat Rev Cardiol. 2010;7(10):551–63. https://doi.org/10.1038/nrcardio.2010.118.CrossRefPubMed

30.

Park JB, Lee SP, Lee JH, et al. Quantification of right ventricular volume and function using single-beat three-dimensional echocardiography: a validation study with cardiac magnetic resonance. J Am Soc Echocardiogr. 2016;29(5):392–401. https://doi.org/10.1016/j.echo.2016.01.010.CrossRefPubMed

31.

Zhu Y, Bao Y, Zheng K, et al. Quantitative assessment of right ventricular size and function with multiple parameters from artificial intelligence-based three-dimensional echocardiography: a comparative study with cardiac magnetic resonance. Echocardiography. 2022;39(2):223–32. https://doi.org/10.1111/echo.15292.CrossRefPubMed

32.

Alandejani F, Hameed A, Tubman E, et al. Imaging and risk stratification in pulmonary arterial hypertension: time to include right ventricular assessment. Front Cardiovasc Med. 2022;9:797561. https://doi.org/10.3389/fcvm.2022.797561.CrossRefPubMedPubMedCentral

33.

Blessberger H, Binder T. Two dimensional speckle tracking echocardiography: basic principles. Heart. 2010;96(9):716–22. https://doi.org/10.1136/hrt.2007.141002.CrossRefPubMed

34.

Vos JL, Leiner T, van Dijk APJ, et al. Right atrial and ventricular strain detects subclinical changes in right ventricular function in precapillary pulmonary hypertension. Int J Cardiovasc Imaging. Published online February 21, 2022. https://doi.org/10.1007/s10554-022-02555-6f

35.

Muraru D, Haugaa K, Donal E, et al. Right ventricular longitudinal strain in the clinical routine: a state-of-the-art review. Eur Heart J - Cardiovasc Imaging. Published online February 11, 2022:jeac022. https://doi.org/10.1093/ehjci/jeac022

36.

Mukherjee M, Chung SE, Ton VK, et al. Unique abnormalities in right ventricular longitudinal strain in systemic sclerosis patients. Circ Cardiovasc Imaging. 2016;9(6):e003792. https://doi.org/10.1161/CIRCIMAGING.115.003792.CrossRefPubMed

37.

Kallifatidis A, Mouratoglou SA, Giannakoulas G, Finitsis S, Karvounis H, Sianos G. Myocardial deformation assessment in patients with precapillary pulmonary hypertension: a cardiac magnetic resonance study. Diagn Interv Imaging. 2021;102(3):153–61. https://doi.org/10.1016/j.diii.2020.08.001.CrossRefPubMed

38.

Hardegree EL, Sachdev A, Villarraga HR, et al. Role of Serial quantitative assessment of right ventricular function by strain in pulmonary arterial hypertension. Am J Cardiol. 2013;111(1):143–8. https://doi.org/10.1016/j.amjcard.2012.08.061.CrossRefPubMed

39.

Rich JD, Shah SJ, Swamy RS, Kamp A, Rich S. Inaccuracy of Doppler echocardiographic estimates of pulmonary artery pressures in patients with pulmonary hypertension. Chest. 2011;139(5):988–93. https://doi.org/10.1378/chest.10-1269.CrossRefPubMed

40.

Murata I, Kihara H, Shinohara S, Ito K. Echocardiographic evaluation of pulmonary arterial hypertension in patients with progressive systemic sclerosis and related syndromes. Jpn Circ J. 1992;56(10):983–91. https://doi.org/10.1253/jcj.56.983.CrossRefPubMed

41.

Sumimoto K, Tanaka H, Mukai J, et al. Optimal cut-off of tricuspid regurgitation velocity according to the new definition of pulmonary hypertension - its use in predicting pulmonary hypertension -. Circ Rep. 2020;2(10):625–9. https://doi.org/10.1253/circrep.CR-20-0094.CrossRefPubMedPubMedCentral

42.

Writing Committee Members, McLaughlin VV, Archer SL, et al. ACCF/AHA 2009 Expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in Collaboration With the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 2009;119(16):2250–94. https://doi.org/10.1161/CIRCULATIONAHA.109.192230.CrossRef

43.

Huston JH, Maron BA, French J, et al. Association of mild echocardiographic pulmonary hypertension with mortality and right ventricular function. JAMA Cardiol. 2019;4(11):1112. https://doi.org/10.1001/jamacardio.2019.3345.CrossRefPubMedPubMedCentral

44.

Marra AM, Halank M, Benjamin N, et al. Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study). Respir Res. 2018;19(1):258. https://doi.org/10.1186/s12931-018-0957-y.CrossRefPubMedPubMedCentral

45.

Strange G, Stewart S, Celermajer DS, et al. Threshold of pulmonary hypertension associated with increased mortality. J Am Coll Cardiol. 2019;73(21):2660–72. https://doi.org/10.1016/j.jacc.2019.03.482.CrossRefPubMed

46.

Xiong PY, Jaff Z, D’Arsigny CL, Archer SL, Wijeratne DT. Evaluation of the impact of an echocardiographic diagnosis of pulmonary hypertension on patient outcomes. CJC Open. 2020;2(5):328–36. https://doi.org/10.1016/j.cjco.2020.04.001.CrossRefPubMedPubMedCentral

47.

Dabestani A, Mahan G, Gardin JM, et al. Evaluation of pulmonary artery pressure and resistance by pulsed Doppler echocardiography. Am J Cardiol. 1987;59(6):662–8. https://doi.org/10.1016/0002-9149(87)91189-1.CrossRefPubMed

48.

Abbas AE, Fortuin FD, Schiller NB, Appleton CP, Moreno CA, Lester SJ. A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol. 2003;41(6):1021–7. https://doi.org/10.1016/S0735-1097(02)02973-X.CrossRefPubMed

49.

Rajagopalan N, Simon MA, Suffoletto MS, et al. Noninvasive estimation of pulmonary vascular resistance in pulmonary hypertension. Echocardiography. 2009;26(5):489–94. https://doi.org/10.1111/j.1540-8175.2008.00837.x.CrossRefPubMed

50.

Tei C, Dujardin KS, Hodge DO, et al. Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr. 1996;9(6):838–47. https://doi.org/10.1016/S0894-7317(96)90476-9.CrossRefPubMed

51.

Vonk M, Sander M, Vandenhoogen F, Vanriel P, Verheugt F, Vandijk A. Right ventricle Tei-index: a tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue diseases. Eur J Echocardiogr. 2007;8(5):317–21. https://doi.org/10.1016/j.euje.2006.06.002.CrossRefPubMed

52.

Yeo TC, Dujardin KS, Tei C, Mahoney DW, McGoon MD, Seward JB. Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. Am J Cardiol. 1998;81(9):1157–61. https://doi.org/10.1016/S0002-9149(98)00140-4.CrossRefPubMed

53.

Tello K, Dalmer A, Axmann J, et al. Reserve of right ventricular-arterial coupling in the setting of chronic overload. Circ Heart Fail. 2019;12(1):e005512. https://doi.org/10.1161/CIRCHEARTFAILURE.118.005512.CrossRefPubMed

54.

Hsu S. Coupling right ventricular–pulmonary arterial research to the pulmonary hypertension patient bedside. Circ Heart Fail. 2019;12(1):e005715. https://doi.org/10.1161/CIRCHEARTFAILURE.118.005715.CrossRefPubMed

55.

Mukherjee M, Mercurio V, Balasubramanian A, et al. Defining minimal detectable difference in echocardiographic measures of right ventricular function in systemic sclerosis. Arthritis Res Ther. 2022;24(1):146. https://doi.org/10.1186/s13075-022-02835-5.CrossRefPubMedPubMedCentral

Titel: Case-Based Discussion: Echocardiographic Assessment of Pulmonary Hypertension
verfasst von: Brigitte Kazzi
Allison G. Hays
Lena M. Mathews
Erin D. Michos
Stephen C. Mathai
Monica Mukherjee
Publikationsdatum: 01.03.2023
Verlag: Springer US
Erschienen in: Current Cardiovascular Imaging Reports / Ausgabe 2/2023
Print ISSN: 1941-9066
Elektronische ISSN: 1941-9074
DOI: https://doi.org/10.1007/s12410-023-09575-3

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Kardiologie

Risiko für Optikusneuropathie unter Semaglutid in Studie erhöht

28.04.2025
Anteriore ischämische Optikusneuropathie
Nachrichten

In einer retrospektiven Kohortenstudie war das Risiko, eine bestimmte Form von Optikusneuropathie zu entwickeln, bei Diabeteskranken unter Semaglutid erhöht. Das Studiendesign gibt allerdings Anlass zu Zweifeln.

Lipidtherapie im Praxisalltag: Noch viel Spielraum für Verbesserung

25.04.2025
DGK-Jahrestagung 2025
Kongressbericht

Wie steht es um die Behandlung von Dyslipidämien bei Risikopatienten mit atherosklerotischer Gefäßerkrankung in Deutschland? Eine Bestandsaufnahme dazu liefert das bei der DGK-Tagung 2025 vorgestellte Forschungsprojekt LipidSnapshot.

Schützen GLP1-Rezeptor-Agonisten vor kardiovaskulären Komplikationen nach Pneumonie?

24.04.2025
DGP 2025
Kongressbericht

Kardiovaskuläre Ereignisse nach Lungeninfektionen sind häufig, doch pathophysiologisch wenig verstanden. Dass womöglich Glukagon daran Anteil hat, eröffnet neue therapeutische Perspektiven.

Beeinträchtigte Ventrikelfüllung erhöht die COPD-Mortalität

24.04.2025
COPD
Nachrichten

Patienten mit chronisch obstruktiver Lungenerkrankung und eingeschränkter Füllung der linken Herzkammer haben ein erhöhtes Sterberisiko. Dabei sind zwei Formen des Füllungsdefizits zu unterscheiden, wie eine Studie zeigt.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Jetzt 10 CME-Punkte sammeln

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Case-Based Discussion: Echocardiographic Assessment of Pulmonary Hypertension